WideCells Group PLC CellPlan Launch in Spain

WideCells’ CEO, João Andrade, said, “We are delighted to launch CellPlan in Spain, one of the most established stem cell markets in Europe. Given the positive uptake and interest shown from new Stem Cell clients, with no marketing campaigns yet implemented, we are confident that the launch of our ecommerce platform and full sales activities will prove fruitful. Stem Cell is a quality provider of stem cell storage services and with a current client base of c.22,000, which is growing daily, we are delighted to be working with its team to build our sales profile. Alongside this, the newly launched ecommerce platform will enable CellPlan to be purchased by anyone in Spain that has stored stem cells with a facility approved by us, maximising market potential. With a highly competitive product that has clear market demand and a scalable roll-out model, we look forward to providing more families with access to our end-to-end stem cell services and building revenues for the Group.”

WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is pleased to announce the launch in Spain of its bespoke ecommerce platform focused on CellPlan, its unique stem cell insurance product, as part of the Group’s expansion into this key geographic region.

Highlights

· Innovative stem cell insurance product CellPlan now available for nationwide purchase in Spain following launch on 27 July 2018 via bespoke ecommerce platform

· Provides sales exposure to one of the most established cord blood and stem cell storage markets in Europe in line with strategy to build sales and revenue profile

· Follows successful soft launch in May 2018 to new clients of established provider of stem cell storage services, Stem Cell Banco Celulas Madre, S. A., (‘Stem Cell’) – 20+ sales secured within two months marking a 100% conversion rate of Stem Cell new clients in May and June

· Active marketing campaign to commence targeting Stem Cell’s existing 22,000 clients as well as the wider Spanish market – anyone in Spain that has stored stem cells in a facility that meets CellPlan Excel stringent quality criteria can now purchase CellPlan via the ecommerce platform

· Discussions underway with additional stem cell storage facilities in Spain to maximise market penetration

Further Information

A new corporate website for CellPlan has been launched in Spain and is available to view at www.cellplan.com/es (an English version is also available to view at www.cellplan.com). This follows the successful soft launch of the service in May 2018 with established provider of stem cell storage services, Stem Cell, which reported that all new clients signed up during May and June had signed an application form for CellPlan, with the policy to be issued when the platform goes live, and payment is completed. This translates to 20+ sales and with new clients continuing to be secured by Stem Cell, this figure is set to increase further.

The Group is now focused on implementing an active marketing campaign in Spain to attract new users to its services via Stem Cell’s existing 22,000 clients as well as the wider Spanish market. To this end, discussions are underway with additional stem cell storage facilities in Spain and the Group continues to target additional growth opportunities in Europe. Furthermore, positive progress continues to be made regarding the launch of CellPlan in Brazil, Thailand, India and Singapore as part of the Group’s agreements with leading Brazilian storage facility Hemocord Clinica Medica Ltd and Asia-Pac focussed Cryoviva Group. Phased roll-out in these new territories is expected to commence in late 2018 / H1 2019 in line with the Group’s global growth strategy. Further updates will be announced in due course.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing